Austin, TX, United States of America

Brigitte Brieschke

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Brigitte Brieschke: Innovator in Therapeutic Technologies

Introduction

Brigitte Brieschke is a prominent inventor based in Austin, TX, known for her significant contributions to the field of therapeutic technologies. With a focus on developing innovative solutions for medical applications, she has been awarded a total of 3 patents that showcase her expertise and dedication to advancing healthcare.

Latest Patents

One of her latest patents is titled "De-immunized Shiga toxin a subunit effector polypeptides for applications in mammals." This invention relates to Shiga toxin effector polypeptides that possess reduced antigenic and/or immunogenic potential. The reduced immunogenicity allows for repeated administration of these proteins and polypeptides derived from Shiga toxins, which can be crucial for therapeutic, diagnostic, and immunization purposes. The cytotoxic proteins developed in this patent are designed for the selective killing of specific cell types and can be utilized in treating various diseases, including cancers, immune disorders, and microbial infections.

Another notable patent is "Cell-targeting molecules comprising de-immunized, Shiga toxin a subunit effectors and CD8+ T-cell epitopes." This invention provides cell-targeting molecules capable of delivering CD8+ T-cell epitope cargo to the MHC class I presentation pathway of target cells. These molecules can be used to target and label specific cell types, including malignant and non-immune cells, thereby stimulating beneficial immune responses. The applications of this technology extend to treating a range of diseases, disorders, and conditions, such as cancers, tumors, immune disorders, and microbial infections.

Career Highlights

Brigitte Brieschke is currently associated with Molecular Templates, Inc., where she continues to innovate and develop groundbreaking therapeutic technologies. Her work has positioned her as a key figure in the field, contributing to advancements that have the potential to improve patient outcomes significantly.

Collaborations

Throughout her career, Brigitte has collaborated with notable professionals in her field, including Eric Poma and Erin Willert. These collaborations have further enhanced her research and development efforts, leading to impactful innovations.

Conclusion

Brigitte Brieschke's work exemplifies the spirit of innovation in therapeutic technologies. Her patents reflect a commitment to addressing critical health challenges through scientific advancements. As she continues her work at Molecular Templates, Inc., her

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…